Inhibition of monoacylglycerophosphate formation by chlorophenoxyisobutyrate and  -benzalbutyrate.
D000215:Acylation; D000217:Acyltransferases; D000418:Albumins; D000475:Alkenes / Q000494:pharmacology*; D000818:Animals; D002087:Butyrates / Q000494:pharmacology*; D002247:Carbon Isotopes; D002994:Clofibrate / Q000494:pharmacology*; D003065:Coenzyme A / Q000378:metabolism; D005989:Glycerides / Q000096:biosynthesis; D005994:Glycerophosphates / Q000378:metabolism; D000960:Hypolipidemic Agents / Q000494:pharmacology; D008660:Metabolism / Q000187:drug effects; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism*; D010169:Palmitic Acids / Q000378:metabolism; D010743:Phospholipids / Q000096:biosynthesis*; D011485:Protein Binding; D051381:Rats; D014280:Triglycerides / Q000096:biosynthesis
D000418:Albumins; D000475:Alkenes; D002087:Butyrates; D002247:Carbon Isotopes; D005989:Glycerides; D005994:Glycerophosphates; D000960:Hypolipidemic Agents; D010169:Palmitic Acids; D010743:Phospholipids; D014280:Triglycerides; D000217:Acyltransferases; D002994:Clofibrate; D003065:Coenzyme A